Skip to main content

Cencora, Inc.

corporate_fare Company Profile

Cencora, Inc.

COR·NYSE·Life Sciences·CIK 0001140859

Cencora, Inc. is a global pharmaceutical sourcing and distribution services company that helps healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The company provides innovative programs and services to increase the effectiveness and efficiency of the pharmaceutical supply chain for both human and animal health. Cencora distributes a comprehensive range of brand-name, specialty brand-name, and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services. Its customers include acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, physician practices, medical and dialysis clinics, and veterinarians in the United States and select global markets. Additionally, Cencora offers healthcare providers and pharmaceutical manufacturers various related services, such as data analytics, outcomes research, reimbursement and pharmaceutical consulting services (including regulatory affairs, development consulting and scientific affairs, pharmacovigilance, and quality management and compliance), niche premium logistics services, inventory management, pharmacy automation, pharmacy management, and packaging solutions.

Cencora, Inc. (NYSE:COR) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 28 items for COR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 9 rated 8 or above. Recent SEC coverage for COR spans 8-K, 10-Q.

Recent high-impact activity:

  • FTC Sues to Block $3.5B Cencora Vet-Unit Sale to Covetrus
  • Cencora Recasts Financials Into Three New Segments Starting Fiscal 2027
  • Cencora Beats on Q4 Adjusted EPS of $4.66, Guides FY27 to $19.40-$19.75 and Raises Dividend 10%
  • Cencora Posts $2.71 Q4 EPS as Drug Distributor Closes Fiscal Year
  • Cencora to Buy American Oncology Network for $2.4B Enterprise Value; Lifts FY26 EPS View

Financial Snapshot

Fiscal year ended September 30, 2025
Revenue
$321.33B
Net Income
$1.55B
Diluted EPS
$7.96
Op. Cash Flow
$3.88B
Free Cash Flow
$3.21B
Gross Profit
$11.48B
Operating Income
$2.63B
Cash & Equivalents
$4.36B
Total Debt
$7.66B
Debt / Equity
5.08×
Net Margin
0.5%
Shares Outstanding
193.94M sh
Source: 10-K · filed 2025-11-25 · accession 0001140859-25-000131

Short Interest & Short Volume

2.60 days to cover

FINRA reported short interest of 3,155,491 shares in COR as of the October 30, 2026 settlement, a 19.7% decrease from the prior period — about 2.6 days to cover at its recent average daily volume. On November 20, 2026, 68.3% of COR volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)3,155,491 shares as of October 30, 2026
Change vs prior period▼ 19.7%
Days to cover2.60 at avg daily volume of 1,214,506
Daily short volume (FINRA facilities)68.3% of 350,755 shares on November 20, 2026
5-day average short volume47.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with C →
$339 -0.03% today
52-week range · as of 2026-11-04 $244.82 – $377.54
Market cap
$64.71B
Volume
1.2M (0.9× avg)
3-mo avg 1.4M
Live data · 2026-11-22 04:03 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed COR - Latest Insights

COR
Nov 13, 2026, 11:43 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $356.14
Real-time Price: $339.00 info
Change: -$17.13 (-5%) info
Market Cap: $64.708B info
COR
Nov 04, 2026, 9:25 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $345.75
Real-time Price: $339.00 info
Change: -$6.75 (-2%) info
Market Cap: $64.708B info
COR
Nov 04, 2026, 6:37 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $342.67
Real-time Price: $339.00 info
Change: -$3.67 (-1%) info
Market Cap: $64.708B info
COR
Nov 04, 2026, 6:35 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $343.67
Real-time Price: $339.00 info
Change: -$4.67 (-1%) info
Market Cap: $64.708B info
COR
Oct 21, 2026, 7:48 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $342.51
Real-time Price: $339.00 info
Change: -$3.51 (-1%) info
Market Cap: $64.708B info
COR
Oct 21, 2026, 7:30 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $342.51
Real-time Price: $339.00 info
Change: -$3.51 (-1%) info
Market Cap: $64.708B info
COR
Aug 05, 2026, 12:44 PM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $318.28
Real-time Price: $339.00 info
Change: +$20.72 (+7%) info
Market Cap: $64.708B info
COR
Aug 05, 2026, 8:05 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $316.06
Real-time Price: $339.00 info
Change: +$22.94 (+7%) info
Market Cap: $64.708B info
COR
Aug 05, 2026, 6:33 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $307.02
Real-time Price: $339.00 info
Change: +$31.98 (+10%) info
Market Cap: $64.708B info
COR
Aug 05, 2026, 6:32 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $307.02
Real-time Price: $339.00 info
Change: +$31.98 (+10%) info
Market Cap: $64.708B info
COR
Aug 04, 2026, 1:53 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $307.95
Real-time Price: $339.00 info
Change: +$31.05 (+10%) info
Market Cap: $64.708B info
COR
Jun 15, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $281.43
Real-time Price: $339.00 info
Change: +$57.57 (+20%) info
Market Cap: $64.708B info
COR
May 29, 2026, 5:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $269.36
Real-time Price: $339.00 info
Change: +$69.64 (+26%) info
Market Cap: $64.708B info
COR
May 27, 2026, 8:01 AM EDT
Source: dpa-AFX
Importance Score:
7
Price at Filing: $271.24
Real-time Price: $339.00 info
Change: +$67.76 (+25%) info
Market Cap: $64.708B info
COR
May 21, 2026, 5:11 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $264.25
Real-time Price: $339.00 info
Change: +$74.75 (+28%) info
Market Cap: $64.708B info
COR
May 21, 2026, 4:32 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $267.77
Real-time Price: $339.00 info
Change: +$71.23 (+27%) info
Market Cap: $64.708B info
COR
May 06, 2026, 2:41 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $252.82
Real-time Price: $339.00 info
Change: +$86.18 (+34%) info
Market Cap: $64.708B info
COR
May 06, 2026, 7:39 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $288.00
Real-time Price: $339.00 info
Change: +$51.00 (+18%) info
Market Cap: $64.708B info
COR
May 06, 2026, 6:32 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $309.00
Real-time Price: $339.00 info
Change: +$30.00 (+10%) info
Market Cap: $64.708B info
COR
Mar 23, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $326.76
Real-time Price: $339.00 info
Change: +$12.24 (+4%) info
Market Cap: $64.708B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets